01
February 2024 Feb 2024
Posted February 01, 2024
Monash University Centre for Medicine Use and Safety investigators are urgently seeking expressions of interest from general practice clinics for this well-remunerated study to deliver tailored intervention or provide usual care in patients with chronic obstructive pulmonary disease (COPD).
‘Treatable traits’ (TTs) refers to individually assessing patients for a specified set of treatable problems, followed by the development and implementation of an individualised treatment programme. The aim of this research project is to evaluate the efficacy of a practice nurse-coordinated intervention - Targeting Treatable Traits in COPD to Prevent Hospitalisations (TERRACOTTA) – in the Australian primary care. The goal is to improve quality of life in patients with COPD and reduce hospitalisations.
In the TERRACOTTA trial, disease management targeting TT will be delivered by an interdisciplinary team of general practitioners (GPs), practice nurses, pharmacists, physiotherapists and other allied health professionals.
Click here for further information about the study. View Project Flyer and Explanatory Statement for GP Practices.
Contact Ingrid Sand, TERRACOTTA Project Manager. terracotta@monash.edu or phone: 0412 234 012 for further information.
Subscribe to our mailing list to get all the latest news updates delivered to your inbox.
Aged care is currently experiencing immense change based on the recommendations of the Royal Commission into Aged Care Quality and Safety. Much of this change is being led by the Australian Government and by aged care providers. As researchers, we want to understand how we can best support this change. We want to know what you think are most critical areas to research in residential aged care.
Do you work with people with heart disease? We want to know your perceptions on using genetics to inform nutrition interventions.
The ALIGNED study may help your patients with depression find the right antidepressant medication.